Skip to main content

Table 2 Univariate and multivariate analyses of SPAG5 expression and overall survival

From: SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma

Variables

Univariate analysis

Multivariate analysis

HR (95% CI)

P value

HR (95% CI)

P value

Overall survival

 Age (< 49 vs. ≥49 years)

0.954 (0.757–1.203)

0.692

  

 Gender (female vs. male)

1.008 (0.667–1.522)

0.971

  

 HBV (positive vs. negative)

1.094 (0.816–1.466)

0.549

  

 Liver cirrhosis (yes vs. no)

0.877 (0.612–1.256)

0.474

  

 Tumor size (< 5 vs. ≥5 cm)

1.560 (1.176–2.069)

0.002

1.217 (0.877–1.689)

0.240

 Tumor multiplicity (single vs. multiple)

1.361 (1.072–1.729)

0.011

0.890 (0.660–1.202)

0.448

 Tumor capsule (absent vs. present)

0.528 (0.411–0.677)

0.000

0.645 (0.490–0.850)

0.002

 AFP (< 20 vs. ≥20 ng/mL)

1.526 (1.167–1.994)

0.002

1.329 (1.000–1.766)

0.050

 Vascular invasion (yes vs. no)

2.081 (1.556–2.784)

0.000

1.243 (0.894–1.729)

0.196

 Tumor differentiation

1.363 (1.045–1.777)

0.022

1.116 (0.846–1.473)

0.438

 LNM (yes vs. no)

1.652 (1.076–2.538)

0.022

1.290 (0.824–2.019)

0.266

 TNM (I-II vs. III-IV)

1.905 (1.498–2.424)

0.000

1.356 (0.959–1.917)

0.085

 SPAG5 expression (low vs. high)

0.954 (0.757–1.203)

0.000

1.697 (1.322–2.178)

0.000

  1. AFP a-fetoprotein, HBsAg hepatitis B surface antigen, LNM lymph node metastasis, HR hazard ratio, CI confidence interval